Upgrade to SI Premium - Free Trial

TD Cowen Reiterates Buy Rating on Boston Scientific (BSX), sees creative setup for 2027

August 25, 2026 7:32 AM
TD Cowen analyst Joshua Jennings reiterated a Buy rating and $56.00 price target on Boston Scientific (NYSE: BSX).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments

Next Articles